The Supreme Court Struck Down IEEPA Tariffs – What Medtech Needs To Know
March 31, 2026
1:00 PM
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, ruling that the International Emergency Economic Powers Act (IEEPA) does not authorize the President to impose tariffs. While the ruling brings predictability in one area, several issues remain, including other avenues for tariffs and duty recovery for IEEPA tariffs from U.S. Customs and Border Protection (CBP). Gain critical legal and policy analysis to help your organization respond in real time.
Who Should Attend
- Regulatory affairs and legal counsel
- Trade compliance and logistics professionals
- Government affairs and policy teams
- Product and global market strategists
- MedTech exporters seeking tariff mitigation strategies
Panelists
Moderator: Bobby Patrick, Senior Vice President, Government Affairs, AdvaMed
Bobby Patrick leads AdvaMed’s state affairs work and partnerships with external stakeholders, including state biotech trade associations and patient advocacy groups. Previously, Bobby served as the vice president of strategic growth and policy at the Medical Alley Association, a Minnesota-based state healthcare trade association, where he led the state and federal advocacy efforts, as well as membership growth and retention.
Sally Laing, Partner, International Trade, Akin
Drawing on 15 years of executive branch, congressional and private practice experience, Sally advises clients on the intersection of international trade law and U.S. public policy. In this capacity, she guides clients through complex strategic decisions regarding regulatory compliance, supply chain resiliency and overcoming trade barriers. Leveraging experience as a senior government official, Sally is able to counsel clients on cutting-edge trade issues, industrial policy and other emerging challenges.
Devin S. Sikes, Partner, Akin
Devin helps government and corporate clients across the globe navigate complex international trade laws and policies to seize opportunities and avoid risks. With a particular focus on trade policy and trade remedy matters, Devin has represented corporations, big and small, across numerous industries, as well as counseled industry associations and sovereigns.
Hear From Us
Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.